OncoZenge AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 16, 2022 at 11:30 am IST
OncoZenge AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was SEK 2.82 million compared to SEK 1 million a year ago. Basic loss per share from continuing operations was SEK 0.24 compared to SEK 0.09 a year ago.
For the six months, net loss was SEK 38.88 million compared to SEK 2.01 million a year ago. Basic loss per share from continuing operations was SEK 3.2 compared to SEK 0.17 a year ago.